Senior insider sale
Sr. VP and Head of Tech Op at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$768.4K
50K shares
What this filing means
LUND-HANSEN TORBEN plans to sell 50K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $768.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/28/2024ACC: 0001964306-24-000328
Officer· Sr. VP and Head of Tech Op
Since Sep 2018
50K
Shares to sell
$768.4K
Approx. market value
50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of employee stock options
Broker assisted cashless exercise
8/28/2024
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/28/2024 | Exercise of employee stock options Broker assisted cashless exercise | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
50K
Market value
$768.4K
8/28/2024
Total
Units
50K
Value
$768.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/28/2024 | 50K | $768.4K | NASDAQ | Planned |
| Total | 50K | $768.4K | ||